About the Authors
- Jun Wang
-
Affiliations Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America, Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, New York New York, United States of America
- David Land
-
Affiliation Medisyn Technologies, Inc. Minnetonka, Minnesota, United States of America
- Kenjiro Ono
-
Affiliation Department of Neurology and Neurobiology of Aging, Kanazawa University, Kanazawa, Japan
- Jorge Galvez
-
Affiliation Molecular Topology & Drug Design Unit, University of Valencia, Valencia, Spain
- Wei Zhao
-
Affiliation Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America
- Prashant Vempati
-
Affiliation Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America
- John W. Steele
-
Affiliation Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America
- Alice Cheng
-
Affiliation Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America
- Masahito Yamada
-
Affiliation Department of Neurology and Neurobiology of Aging, Kanazawa University, Kanazawa, Japan
- Samara Levine
-
Affiliation Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America
- Paolo Mazzola
-
Affiliation Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America
- Giulio M. Pasinetti
-
* E-mail: giulio.pasinetti@mssm.edu
Affiliations Department of Neurology, Mount Sinai School of Medicine, New York, New York, United States of America, Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, New York New York, United States of America
Competing Interests
We have read the journal's policy and have the following conflicts: David Land is affiliated with Medisyn Technologies, Inc. The authors also hold a patent: “Compositions for treatment of Alzheimer's disease using abeta-reducing and/or abeta-anti-aggregation compounds”. Mount Sinai School of Medicine of New York University, USA, Inc Medisyn Technologies, editors. Patent Application Country: Application: WO; WO; Priority Application Country: US patent WO2010114636. 2010 1007; Patent Application Date: 20100405.; Priority Application Date: 20090403). There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JW DL MY GMP. Performed the experiments: JW KO JG WZ PV JS AC PM. Analyzed the data: JW JG DL SL GMP. Wrote the paper: JW SL GMP.